ESR1 and breast cancer: To classify the molecular subtypes of breast cancer, the status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) has been considered [5], and the discrimination of these subtypes is crucial for determining treatment options and selecting anticancer agents.